Literature DB >> 1715830

NCI-Black-Reiter (NBR) male rats fail to develop renal disease following exposure to agents that induce alpha-2u-globulin (alpha 2u) nephropathy.

D R Dietrich1, J A Swenberg.   

Abstract

The NCI-Black-Reiter (NBR) rat is the only strain of male rat known not to synthesize the hepatic form of the low molecular weight protein, alpha 2u-globulin. In previous studies, NBR rats were shown not to develop renal disease when exposed to decalin, a compound known to induce alpha 2u-globulin nephropathy in other rat strains. The objective of this study was to show that the presence of alpha 2u-globulin (alpha 2u) is essential for the development of this syndrome in rats exposed to 2,2,4-trimethylpentane (TMP), 1,4-dichlorobenzene (DCB), isophorone (IP), PS-6 unleaded gasoline (UG), and d-limonene (d-L). The induction of alpha 2u-nephropathy in F344 male rats with lindane was used as a positive control and this response was contrasted to male NBR and female F344 rats treated with lindane. Five to seven 11-week-old male NBR rats were exposed to TMP (500 mg/kg/day), DCB (500 mg/kg/day), IP (1000 mg/kg/day), UG (500 mg/kg/day), d-L (1650 mg/kg/day), or lindane (10 mg/kg/day) and five 11-week-old male and female F344 rats were exposed to lindane (10 mg/kg/day) by oral gavage on 4 consecutive days. NBR male and F344 male and female rats gavaged with corn oil were incorporated in the study as vehicle controls. The presence of hyaline droplets was assessed in perfusion-fixed kidneys by staining paraffin sections with Mallory-Heidenhein stain and in GMA sections with Lee's methylene basic blue fuchsin stain. Paraffin sections were also analyzed immunohistochemically for the presence of alpha 2u. Under exposure conditions that clearly induce alpha 2u-nephropathy in male F344 rats, no lesions, hyaline droplets, or alpha 2u were detectable in treated or control male NBR and female F344 rats. It is thus concluded that the presence of alpha 2u is causal to the development of renal disease in rats exposed to TMP, DCB, IP, UG, d-L, and lindane.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715830     DOI: 10.1016/0272-0590(91)90161-v

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  7 in total

1.  Doubting nongenotoxic mechanisms of renal cancer: comparing apples and oranges in the alpha2u-globulin hypothesis.

Authors:  D R Dietrich
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

Review 2.  Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.

Authors:  R L Melnick; M C Kohn; C J Portier
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

3.  Lack of chemoprevention effects of the monoterpene d-limonene in a rat multi-organ carcinogenesis model.

Authors:  J Kimura; S Takahashi; T Ogiso; Y Yoshida; K Akagi; R Hasegawa; M Kurata; M Hirose; T Shirai
Journal:  Jpn J Cancer Res       Date:  1996-06

Review 4.  Hazard evaluation of chemicals that cause accumulation of alpha 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats.

Authors:  G C Hard; I S Rodgers; K P Baetcke; W L Richards; R E McGaughy; L R Valcovic
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

5.  Retrospective study of possible alpha-2 mu-globulin nephropathy and associated cell proliferation in male Fischer 344 rats dosed with t-butyl alcohol.

Authors:  K Takahashi; C Lindamood; R R Maronpot
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

Review 6.  Interpretation of male rat renal tubule tumors.

Authors:  I S Rodgers; K P Baetcke
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

Review 7.  Alpha 2u-globulin nephropathy: review of the cellular and molecular mechanisms involved and their implications for human risk assessment.

Authors:  J A Swenberg
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.